3386 Share Price | Cosmo Bio Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Cosmo Bio Co., Ltd. with Similar Stocks

Premier Anti-Aging Co., Ltd.DVx, Inc.OLBA HEALTHCARE HOLDINGS, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Positive results in Mar 26

RAW MATERIAL COST(Y) Fallen by 0.42% (YoY)
INVENTORY TURNOVER RATIO(HY) Highest at 7.33 times
NET SALES(Q) Highest at JPY 3,331 MM

With ROE of 3.81%, it has a very attractive valuation with a 0.79 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

JPY 7,475 Million (Micro Cap)

P/E

21.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.34

Return on Equity

3.81%

Price to Book

0.79

Revenue and Profits:

Net Sales:

3,331 Million

(Quarterly Results - Mar 2026)

Net Profit:

233 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

12.17%

6 Months

7.24%

1 Year

20.89%

2 Years

31.64%

3 Years

15.19%

4 Years

-0.16%

5 Years

-3.64%

Cosmo Bio Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.18%

EBIT Growth (5y)

-18.60%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

1.12

Tax Ratio

33.01%

Dividend Payout Ratio

84.38%

Pledged Shares

Institutional Holding

ROCE (avg)

10.39%

ROE (avg)

6.86%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.79

EV to EBIT

12.44

EV to EBITDA

8.16

EV to Capital Employed

0.68

EV to Sales

0.39

PEG Ratio

0.90

Dividend Yield

ROCE (Latest)

5.47%

ROE (Latest)

3.81%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 7.69% vs 5.10% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 5.91% vs -8.33% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,331.00",
          "val2": "3,093.00",
          "chgp": "7.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "318.00",
          "val2": "308.00",
          "chgp": "3.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "4.00",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "233.00",
          "val2": "220.00",
          "chgp": "5.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.70%",
          "val2": "88.60%",
          "chgp": "-0.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.26% vs 7.46% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.79% vs -41.65% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,766.00",
          "val2": "10,037.00",
          "chgp": "7.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "509.00",
          "val2": "455.00",
          "chgp": "11.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-34.00",
          "val2": "-50.00",
          "chgp": "32.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "333.00",
          "val2": "269.00",
          "chgp": "23.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.80%",
          "val2": "31.80%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

3,331.00

3,093.00

7.69%

Operating Profit (PBDIT) excl Other Income

318.00

308.00

3.25%

Interest

0.00

Exceptional Items

3.00

4.00

-25.00%

Consolidate Net Profit

233.00

220.00

5.91%

Operating Profit Margin (Excl OI)

81.70%

88.60%

-0.69%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 7.69% vs 5.10% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 5.91% vs -8.33% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

10,766.00

10,037.00

7.26%

Operating Profit (PBDIT) excl Other Income

509.00

455.00

11.87%

Interest

0.00

Exceptional Items

-34.00

-50.00

32.00%

Consolidate Net Profit

333.00

269.00

23.79%

Operating Profit Margin (Excl OI)

31.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7.26% vs 7.46% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 23.79% vs -41.65% in Dec 2024

All Annual Results

Company CV

About Cosmo Bio Co., Ltd.

Cosmo Bio Co., Ltd.

Retailing

No Details Available.

Company Coordinates

No Company Details Available